Summary
Join S&P Global Ratings leading healthcare analysts for an interactive discussion on the team's latest highlights on the industry, concerns they are keeping an eye on, and early thoughts for 2026.
Key Topics:
- Updated views on ratings outlook for the healthcare industry.
- Thoughts on the Big Beautiful Bill Act and its impact.
- Health insurers’ continued struggles.
- Tariffs another headwind for pharma sector.
- Early thoughts going into 2026.
Speakers:
Ryan Gilmore, Director - Medical Devices
David Peknay, Director - Healthcare Services
Francesca Mannarino, Associate Director – Managed Care
Scott Zari, Director - Pharmaceuticals and Life Sciences
Moderator:
Arthur Wong, Managing Director, Sector Lead – Health Care
Contact Us
If you have more questions, please feel free to contact our team